For a more in-depth look at the emerging cannabis space, check out Marketfy’s 420 Investor or grab a ticket to the Cannabis Capital Conference.
A Global Plunge
The Global Cannabis Stock Index struck a 2018 low as it fell 10 percent in July. Only eight of 53 components posted gains.
The month’s concessions, weighed down by the hot selling Canadian licensed producers, brought the index’s year-to-date decline from 29.5 percent to 36.6 percent. It still trades up more than 58 percent from its nadir in October.
A National Embrace
Pharmacies in Italy were given a green light to sell medical cannabis.
“I will make every effort to ensure that medical cannabis is available in all pharmacies to ensure the continuity of treatment to which you are entitled,” Health Minister Giulia Grillo said on Facebook.
The government also said it would legalize production for private companies in order to meet the nation’s rising demand. Until now, the government-run Military Pharmaceutical Plant is the only entity allowed to produce. Its inability to meet demand has led to a surge in black market activity and imports from the Netherlands and Canada.
Officials have not yet announced a date for the distribution and production expansions.
Related Links:
Hold Your Beer: Molson Coors Is Getting Into Cannabis
Compass Cannabis Clinic Gears Up For Expansion Into Global Markets
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Your update on what’s going on in the Fintech space. Keep up-to-date with news, valuations, mergers, funding, and events. Sign up today!